- The best-supported "supplement" intervention in asthma isn't a capsule at all — it's medically administered IV magnesium sulfate for selected severe acute attacks, per Cochrane (odds ratio 0.10 for admission in the severe subgroup).
- Vitamin D is reasonable to correct a documented deficiency, but an updated Cochrane review found no evidence it reduces exacerbations or improves control in the general asthma population.
- A Cochrane review of 11 trials (419 participants) found insufficient evidence to recommend vitamin C as an asthma therapeutic agent, and an NIH ODS/AHRQ-funded systematic review found omega-3 lacks strong support for clinical effectiveness.
- Coltsfoot and butterbur carry real safety risk: a PubMed-indexed rat study linked coltsfoot to liver tumors in 8 of 12 animals on a high-coltsfoot diet, and NCCIH warns butterbur's pyrrolizidine alkaloids can damage the liver and lungs and may cause cancer.
- Homeopathy, lobelia, essential-oil diffusers, and apple cider vinegar have no reliable asthma evidence — National Asthma Council Australia states explicitly there is no evidence apple cider vinegar benefits asthma, and AAAAI notes essential oils' volatile compounds can actually trigger respiratory symptoms.
Ingredient evidence review · Asthma
No supplement cures asthma, and no supplement replaces controller or reliever inhalers. The only supplement-like intervention with a clear asthma role is magnesium sulfate given medically for selected severe acute attacks; vitamin D is reasonable to correct deficiency but is not proven to prevent attacks in the general asthma population. Omega-3, vitamin C, and antioxidant supplements have weak or insufficient evidence, while homeopathic remedies, lobelia, coltsfoot, apple cider vinegar, essential oils, and “asthma cure” blends should not be used as asthma treatments.
Table of contents
- Answer block
- Evidence summary
- How to judge asthma supplement claims
- All forms and types of asthma supplements
- Proven or conditionally useful options
- Popular options with weak, mixed, or no evidence
- Debunked or risky asthma remedies
- Risks and all side effects
- All interactions
- What works and what does not
- Frequently asked questions
- Sources
Answer block
The best-supported “supplement” claim in asthma is not an over-the-counter capsule: it is medically administered magnesium sulfate for selected severe acute asthma attacks. Vitamin D can be important if a person is deficient, but updated Cochrane evidence does not support routine vitamin D supplementation to reduce asthma attacks in the general asthma population. Omega-3, vitamin C, selenium, vitamin E, homeopathy, butterbur, lobelia, coltsfoot, essential oils, and apple cider vinegar should not be treated as asthma therapies.
Evidence summary
| Ingredient / remedy | Evidence | Funding / conflict check | Verdict |
|---|---|---|---|
| IV magnesium sulfate | Cochrane found no routine benefit for all acute asthma patients, but severe subgroup hospital admissions were reduced and no clinically important vital-sign or adverse-effect changes were reported. | Cochrane synthesis; source incentive is systematic evidence accuracy, not supplement sales. | Works in severe acute care |
| Vitamin D | Updated Cochrane review found no evidence supporting vitamin D supplementation to reduce exacerbations or improve control; severe asthma and baseline 25(OH)D below 25 nmol/L were poorly represented. | Cochrane/PubMed; earlier IPD meta-analysis was NIHR-funded and declared no competing interests. | Correct deficiency; not asthma cure |
| Omega-3 | Systematic review found existing trials did not provide strong support for clinical effectiveness and no consistent objective lung-function improvement. | NIH ODS/AHRQ-funded review; authors declared no financial or non-financial competing interests. | Weak/mixed |
| Vitamin C | Cochrane review of 11 trials and 419 participants found insufficient evidence and no current indication to recommend vitamin C as a therapeutic agent in asthma. | Cochrane review; not a brand-funded supplement trial. | Insufficient |
| Selenium / antioxidants | Cochrane selenium review included only one 24-patient trial with unvalidated clinical improvement; vitamin E RCT found no benefit. | Cochrane and PubMed RCT; no retail antioxidant blend used as evidence. | Insufficient / not routine |
| Homeopathy | Cochrane review found insufficient evidence to reliably assess homeopathy’s role in asthma. | Cochrane review; homeopathic product marketing excluded as evidence. | No reliable evidence |
| Butterbur | NCCIH says little research has been done outside migraine and allergic rhinitis and no conclusions can be reached for other conditions; PAs can damage liver/lungs and may cause cancer. | NCCIH and LiverTox public-health sources; no butterbur manufacturer evidence used. | Not asthma treatment; safety caution |
| Lobelia | MSK states current evidence shows lobelia is not effective for asthma and that human asthma data are lacking. | Independent cancer-center integrative medicine monograph; no lobelia seller claim used. | Avoid as asthma treatment |
| Coltsfoot | Coltsfoot contains pyrrolizidine alkaloids; PubMed-indexed animal data linked coltsfoot to liver tumors, and PA hepatotoxicity reviews warn of liver injury. | PubMed/PMC toxicology sources; traditional-use claims excluded as efficacy evidence. | Avoid |
| Essential oils | AAAAI found no direct studies of diffused essential oils in asthma and noted volatile organic compounds can trigger respiratory symptoms; a prospective study associated BVOC/essential-oil components with respiratory symptoms. | AAAAI expert response and university/public-health study with disclosed non-commercial funding and no conflicts. | Trigger risk, not treatment |
| Apple cider vinegar | National Asthma Council Australia states there is no evidence apple cider vinegar is beneficial for asthma. | Independent asthma nonprofit education source; vinegar marketing excluded. | No evidence |
How to judge asthma supplement claims
A supplement claim is not asthma evidence unless it improves asthma outcomes such as exacerbations, oral steroid bursts, emergency visits, lung function, symptom control, or rescue-inhaler use in controlled human studies. Mechanisms such as “anti-inflammatory,” “antioxidant,” “immune support,” or “bronchodilating” are not enough.
GINA warns that asthma should not be treated solely with as-needed SABA and that ICS-containing treatment reduces severe exacerbation risk compared with SABA-only treatment, which means supplement-only asthma management is even less defensible (GINA 2025 Summary Guide).
Text version of this infographic
The strongest asthma supplement evidence comes from randomized controlled trials or systematic reviews showing fewer exacerbations, better lung function, better quality of life, or less rescue-medication use. Observational data and small trials are weaker. Mechanisms, traditional use, and testimonials are not enough to recommend a supplement as asthma treatment.
All forms and grades
| Category | Forms and types | Best-case role | Evidence grade for asthma | Verdict |
|---|---|---|---|---|
| Omega-3 | Fish oil EPA/DHA, algal EPA/DHA, krill oil, cod liver oil, flaxseed ALA, prescription EPA products. | General nutrition or non-asthma indications; asthma evidence weak. | Weak / mixed | Do not buy for asthma control. |
| Vitamin D | D3, D2, calcifediol/calcidiol, calcitriol under medical use, food/sun-derived vitamin D. | Correct documented deficiency and support bone/mineral health. | Mixed; not proven for general asthma control. | Use for deficiency, not as asthma medicine. |
| Magnesium | IV magnesium sulfate, nebulized magnesium sulfate, oral citrate, glycinate, oxide, chloride, malate, threonate, sulfate. | IV use in severe acute asthma under medical care; oral use for deficiency/other indications. | Moderate for IV severe acute care; insufficient for oral asthma control. | Medical tool, not daily asthma supplement. |
| Vitamin C | Ascorbic acid, sodium/calcium ascorbate, buffered C, liposomal C, food vitamin C. | Correct low intake; general nutrition. | Insufficient. | Not an asthma therapy. |
| Antioxidants | Vitamin E, beta-carotene, vitamin A, selenium, zinc, polyphenols, antioxidant blends. | Correct deficiency if present. | Insufficient or negative for routine asthma treatment. | Avoid megadose asthma claims. |
| Botanicals | Butterbur, lobelia, coltsfoot, herbal “lung support” blends. | No reliable asthma-treatment role. | No reliable evidence; some have toxicity concerns. | Avoid as asthma treatment. |
| Homeopathic remedies | Individualized homeopathy, combination asthma pellets/drops, ultra-dilute remedies. | No reliable role. | Insufficient. | Do not use for asthma control or attacks. |
| Aromatherapy / essential oils | Diffusers, inhaled oils, topical oils, vapor rub-style products. | No asthma-treatment role; may irritate. | No reliable efficacy; trigger concern. | Avoid inhaled exposure if asthma-sensitive. |
| Food acids / vinegar remedies | Apple cider vinegar drinks, tonics, gummies. | No asthma role. | No evidence. | Do not use for asthma. |
Text version of this infographic
- Works: IV magnesium sulfate only for selected severe acute asthma in medical care.
- Conditional: vitamin D for deficiency, not as an asthma cure.
- Weak: omega-3, vitamin C, selenium, and antioxidant supplements.
- No reliable evidence: homeopathy, apple cider vinegar, and “asthma cure” supplements.
- Risk concern: lobelia, coltsfoot, and inhaled essential oils.
Proven or conditionally useful options
Magnesium sulfate: works only in a specific medical setting
Intravenous magnesium sulfate is the clearest positive signal, but it is not a retail supplement claim. Cochrane concluded that evidence does not support routine IV magnesium sulfate for all acute asthma patients, but it appears safe and beneficial in severe acute asthma (Cochrane IV magnesium).
The same Cochrane summary reported that hospital admission was not reduced overall, but severe subgroup admissions were reduced with an odds ratio of 0.10 and no clinically important vital-sign or adverse-effect changes were reported (Cochrane IV magnesium). This evidence does not justify daily oral magnesium capsules as asthma control therapy.
Vitamin D: correct deficiency, do not oversell asthma prevention
The updated Cochrane review found no evidence to support vitamin D supplementation or hydroxylated metabolites for reducing asthma exacerbations or improving asthma control, but participants with severe asthma and baseline 25(OH)D below 25 nmol/L were poorly represented (PubMed Cochrane vitamin D review). Earlier individual-participant meta-analysis found fewer exacerbations requiring systemic corticosteroids, but that signal did not survive as a general recommendation after newer trials were added (vitamin D IPD meta-analysis, Cochrane vitamin D news).
The funding trail is important: the earlier individual-participant meta-analysis was funded by the National Institute for Health Research Health Technology Assessment Programme and declared no competing interests (vitamin D IPD meta-analysis). That makes it useful evidence, but the updated Cochrane conclusion is more current for the broad asthma population.
Popular options with weak, mixed, or no evidence
Omega-3: plausible mechanism, weak asthma outcomes
The omega-3 asthma review found that clinical trials did not provide strong support for effectiveness and that objective lung-function outcomes such as FEV1 and peak flow usually failed to show benefit (omega-3 asthma systematic review). The review was requested and funded by NIH ODS under an AHRQ contract, and authors declared no financial or non-financial competing interests, which makes the negative/uncertain conclusion especially credible (omega-3 asthma systematic review).
Vitamin C: not an asthma therapy
Cochrane reviewed 11 trials with 419 participants and found insufficient evidence to evaluate vitamin C as asthma treatment; the authors stated there is no current indication that vitamin C can be recommended as a therapeutic agent in asthma (PubMed Cochrane vitamin C review). Small exercise-induced breathlessness signals were inconclusive and should not be converted into broad asthma claims (Cochrane vitamin C summary).
Selenium, vitamin E, and broad antioxidants
Cochrane’s selenium review found only one 24-person trial and concluded any possible benefit was limited by insufficient studies and lack of improvement in objective lung-function or airway-hyperresponsiveness parameters (selenium Cochrane PubMed). A vitamin E RCT in adults with mild-to-moderate asthma found no benefit over standard treatment (vitamin E asthma RCT).
Broad antioxidant megadoses also have broader safety concerns: a Cochrane mortality review found no evidence to support antioxidant supplements for primary or secondary prevention and noted increased mortality signals for beta-carotene and possibly vitamin E (Cochrane antioxidants).
Debunked or risky asthma remedies
Homeopathic asthma remedies
Cochrane concluded that there is not enough evidence to reliably assess homeopathy’s possible role in asthma (Cochrane homeopathy asthma). Homeopathic products should not be used to delay controller medication, rescue inhalers, oral corticosteroids when medically directed, or emergency care.
Butterbur
NCCIH says little research has been done on butterbur for conditions other than migraine and allergic rhinitis, so no conclusions can be reached for other conditions (NCCIH butterbur). NCCIH also warns that butterbur contains pyrrolizidine alkaloids that can damage the liver and lungs and may cause cancer, and LiverTox notes that butterbur-drug interactions have not been defined (NCCIH butterbur, LiverTox butterbur).
Lobelia
Memorial Sloan Kettering states that current evidence shows lobelia is not effective for asthma or any medical condition, and that human data for asthma are lacking (MSK Lobelia). MSK also notes that lobeline can stimulate the central nervous system at lower doses but cause CNS depression and reduced breathing rate at higher doses, which makes lobelia especially inappropriate for self-treating breathing problems (MSK Lobelia).
Coltsfoot
Coltsfoot has traditional respiratory use, but it contains pyrrolizidine alkaloids with hepatotoxic and carcinogenic concerns. A PubMed-indexed rat study found liver hemangioendothelial sarcoma in 8 of 12 rats in a high coltsfoot diet group and attributed carcinogenicity most probably to senkirkine, a hepatotoxic pyrrolizidine alkaloid (coltsfoot carcinogenicity PubMed).
A review of coltsfoot phytochemistry notes that multiple pyrrolizidine alkaloids have been reported and that latent liver damage should not be ignored, especially in children (coltsfoot review PMC). A broader PubMed review states that herbal remedies containing pyrrolizidine alkaloids can induce liver damage including hepatic sinusoidal obstruction syndrome (PA hepatotoxicity PubMed).
Essential oils for asthma
AAAAI’s expert response says there are no published studies specifically examining diffused essential oils in asthma, while noting that volatile organic compounds can trigger respiratory symptoms (AAAAI essential oil diffusers and asthma). A prospective study reported that widely used essential oil products containing biogenic volatile organic compounds such as linalool were associated with respiratory symptoms, with funding disclosed from academic/asthma foundation sources and no conflicts reported (essential oils and asthma study).
Apple cider vinegar
National Asthma Council Australia states that there is no evidence apple cider vinegar is beneficial for asthma (National Asthma Council Australia). Vinegar can also irritate the throat or worsen reflux in some people, and reflux can aggravate cough or asthma-like symptoms.
Text version of this infographic
- Red flag: a product claims to cure asthma.
- Red flag: a seller suggests stopping prescribed inhalers.
- Red flag: a product is promoted for use during asthma attacks.
- Red flag: a product contains pyrrolizidine alkaloid herbs such as unsafe butterbur or coltsfoot.
- Red flag: essential oil diffusers are promoted as asthma treatment despite lack of asthma efficacy studies.
- Red flag: proprietary blends hide ingredient amounts and make interaction checks impossible.
Risks and all side effects
| Ingredient / remedy | Common side effects | Rare but serious side effects | Who should avoid or use caution | Independent source |
|---|---|---|---|---|
| Omega-3 | Fishy taste, bad breath, heartburn, nausea, GI discomfort, diarrhea, headache, odoriferous sweat. | High-dose use can affect platelet activity; 4 g/day for years slightly increased atrial fibrillation risk in some high-risk cardiovascular trials. | Anticoagulant or antiplatelet users, atrial fibrillation risk, fish/shellfish allergy, surgery planning. | NIH ODS Omega-3 |
| Vitamin D | Usually minimal at appropriate doses. | Hypercalcemia, hypercalciuria, kidney stones, renal failure, soft-tissue calcification, cardiac arrhythmias, death in toxicity. | Kidney disease, hypercalcemia, granulomatous disease, thiazide users, high-dose calcium users. | NIH ODS Vitamin D |
| Oral magnesium | Diarrhea, nausea, abdominal cramping. | Hypermagnesemia, hypotension, weakness, respiratory depression, arrhythmia in toxicity. | Kidney disease, older adults with reduced kidney function, laxative/antacid overuse. | NIH ODS Magnesium |
| IV magnesium sulfate | Flushing, warmth, nausea, low blood pressure in some medical contexts. | Respiratory depression or cardiac conduction effects if excessive or improperly monitored. | Medical use only; caution in renal impairment and neuromuscular disease. | Cochrane IV magnesium |
| Vitamin C | Diarrhea, nausea, abdominal cramps, GI disturbance at high doses. | Kidney-stone concern and iron overload exacerbation in susceptible people. | Kidney-stone history, hemochromatosis, oncology treatment. | NIH ODS Vitamin C |
| Vitamin E / broad antioxidants | GI upset, headache, ingredient-specific effects. | Vitamin E and beta-carotene mortality signals in broad Cochrane review; vitamin E may increase bleeding tendency at high doses. | Smokers using beta-carotene, anticoagulant users, people stacking high-dose antioxidants. | Cochrane antioxidants |
| Butterbur | Belching, diarrhea, drowsiness, rash, stomach upset. | PA-containing products can damage liver/lungs and may cause cancer; liver injury reports exist even with some commercial contexts. | Pregnancy, breastfeeding, liver disease, ragweed/daisy-family allergy, anyone unable to verify PA-free quality. | NCCIH butterbur; LiverTox butterbur |
| Lobelia | Dizziness, nausea, vomiting, throat irritation. | Higher doses can cause CNS depression, reduced breathing rate, cardiovascular toxicity, and toxicity when combined with nicotine-like effects. | Asthma, pregnancy, breastfeeding, heart disease, nicotine-product users, children. | MSK Lobelia |
| Coltsfoot | GI upset possible; product content variable. | Pyrrolizidine alkaloid liver injury, sinusoidal obstruction syndrome, genotoxic/carcinogenic concerns. | Pregnancy, breastfeeding, children, liver disease, anyone using hepatotoxic medicines. | Coltsfoot carcinogenicity PubMed; PA hepatotoxicity PubMed |
| Essential oils / diffusers | Throat/nose irritation, cough, headache, skin allergy with topical use. | Respiratory symptom triggering in susceptible people; accidental poisoning if ingested. | Asthma, allergic rhinitis, children, pets in household, fragrance sensitivity. | AAAAI essential oils; essential oils study |
| Apple cider vinegar | Throat irritation, tooth enamel erosion, reflux symptoms, nausea. | Low potassium and drug interaction concerns are reported with excessive vinegar use, but asthma benefit is unsupported. | Reflux, dental erosion, gastroparesis, potassium-lowering medicines. | National Asthma Council Australia |
All interactions
| Ingredient | Interacts with | Mechanism / effect | Severity | Action |
|---|---|---|---|---|
| Omega-3 | Warfarin, DOACs, aspirin, clopidogrel, other anticoagulant/antiplatelet therapies. | High-dose fish oil can have antiplatelet effects and may affect clotting time. | Caution / monitor | Tell prescriber; monitor bleeding/INR if relevant (NIH ODS Omega-3). |
| Vitamin D | Orlistat. | Reduced absorption of fat-soluble vitamin D. | Monitor | Assess vitamin D status and timing (NIH ODS Vitamin D). |
| Vitamin D | Thiazide diuretics. | Can increase hypercalcemia risk in susceptible people. | Caution | Avoid high-dose self-prescribing; monitor calcium if indicated. |
| Vitamin D | Corticosteroids. | Steroids can impair vitamin D metabolism and calcium absorption. | Monitor | Bone-health and vitamin D review in long-term steroid users. |
| Vitamin D | Statins. | NIH ODS lists statins among medication categories relevant to vitamin D interactions or status context. | Monitor | Discuss high-dose vitamin D with clinician if using chronic statins. |
| Magnesium | Tetracycline and quinolone antibiotics. | Chelation lowers antibiotic absorption and may risk treatment failure. | High | Separate antibiotic at least 2 hours before or 4–6 hours after magnesium. |
| Magnesium | Bisphosphonates. | Reduced bisphosphonate absorption. | Moderate | Separate dosing; follow fasting instructions. |
| Magnesium | Loop/thiazide/potassium-sparing diuretics. | Loop/thiazide drugs can increase magnesium loss; potassium-sparing drugs can increase retention. | Monitor | Use labs and clinician guidance. |
| Magnesium | Kidney disease or reduced eGFR. | Reduced magnesium clearance increases toxicity risk. | Avoid unsupervised use | Use only with clinician supervision. |
| Vitamin C | Chemotherapy and radiation. | NIH ODS notes uncertainty about antioxidant interactions with cancer therapy. | High in active treatment | Use only with oncologist approval. |
| Vitamin C | Iron supplements or hemochromatosis. | Increases non-heme iron absorption and may worsen iron overload at high doses. | Caution | Avoid high-dose use unless directed. |
| Vitamin E / antioxidant blends | Anticoagulants/antiplatelets. | Potential additive bleeding tendency depending on dose and formulation. | Caution | Avoid high-dose unsupervised use. |
| Butterbur | Other herbal products, hepatotoxic medicines, sedatives. | NCCIH says herbs and medicines can interact harmfully; LiverTox states butterbur-drug interactions have not been defined. | Unclear / caution | Avoid unless clinician verifies product and interaction risk. |
| Lobelia | Nicotine products. | Lobeline has nicotine-like activity and can have additive or opposing effects with nicotine. | Avoid | Do not combine; do not use for asthma. |
| Coltsfoot | Hepatotoxic medicines, alcohol-heavy use, other PA-containing herbs. | Additive liver injury risk. | Avoid | Do not use for asthma. |
| Essential oils | Asthma triggers, fragrances, smoke/fumes, sensitizing topical products. | Volatile compounds can irritate airways or trigger symptoms in susceptible people. | Avoid if sensitive | Do not diffuse as asthma treatment. |
| Apple cider vinegar | Reflux, tooth enamel, potassium-lowering medicines. | Acid irritation and potential electrolyte concerns with excessive use. | Caution | Do not use for asthma; avoid if reflux worsens breathing/cough. |
Text version of this infographic
Before using any asthma-related supplement, check for blood thinners, antibiotics, diuretics, kidney disease, liver disease, cancer treatment, and fragrance-triggered asthma. Missing interaction data are not proof of safety; they are a reason to be more cautious.
What works and what does not
| Claimed asthma supplement | Verdict | Evidence | Key caveat |
|---|---|---|---|
| IV magnesium sulfate for severe acute asthma | WORKS | Cochrane severe subgroup showed lower admissions; not routine for all attacks. | Emergency/medical setting only. |
| Oral magnesium for daily asthma control | INSUFFICIENT | IV evidence does not translate to oral supplement controller evidence. | Kidney disease and drug interactions matter. |
| Vitamin D for deficiency | WORKS for deficiency correction | NIH ODS supports vitamin D’s role in calcium/bone physiology. | Asthma attack prevention is not proven broadly. |
| Vitamin D to prevent asthma attacks in everyone | DOESN'T / NOT PROVEN | Updated Cochrane review found no support for reducing exacerbations or improving control. | Severe asthma and very low baseline levels under-studied. |
| Omega-3 fish oil for asthma | MIXED / WEAK | Systematic review found no strong clinical support. | May be useful for other conditions; not asthma therapy. |
| Vitamin C for asthma | INSUFFICIENT | Cochrane found insufficient evidence and no indication to recommend it as therapeutic agent. | Small EIB signals are not enough. |
| Vitamin E | DOESN'T for routine asthma control | RCT found no benefit over standard treatment. | High doses may have broader safety concerns. |
| Selenium | INSUFFICIENT | Cochrane found one 24-person trial with insufficient objective support. | Do not supplement unless deficiency or clinician indication. |
| Homeopathy | INSUFFICIENT / DO NOT RELY | Cochrane evidence insufficient. | Dangerous if it delays inhalers or urgent care. |
| Butterbur | NO ASTHMA EVIDENCE + SAFETY CAUTION | NCCIH: no conclusions for conditions beyond migraine/allergic rhinitis; PA toxicity concern. | PA-free status and liver risk are major issues. |
| Lobelia | DOESN'T / AVOID | MSK: current evidence does not support asthma use; human asthma data lacking. | Breathing-rate depression risk at higher doses. |
| Coltsfoot | AVOID | PA hepatotoxic/carcinogenic concerns. | Not worth the risk for unproven asthma benefit. |
| Essential oils | DOESN'T / POSSIBLE TRIGGER | AAAAI: no diffuser studies in asthma; VOCs can trigger symptoms. | Fragrance-sensitive asthma may worsen. |
| Apple cider vinegar | NO EVIDENCE | National Asthma Council Australia says no evidence of benefit. | Reflux/throat irritation can be counterproductive. |
Text version of this infographic
- If asthma symptoms are worsening, follow the written action plan and seek urgent care for red-zone symptoms.
- If symptoms are not worsening, ask whether a supplement is treating a documented deficiency or another evidence-based non-asthma indication.
- Vitamin D is reasonable for deficiency correction, but not as a broad asthma-attack prevention claim.
- IV magnesium sulfate is a medical acute-care tool, not a daily supplement strategy.
- Do not use supplements as rescue treatment.
Frequently asked questions
What supplement actually works for asthma?
The best-supported supplement-like intervention is intravenous magnesium sulfate for selected severe acute asthma attacks in medical care, not an over-the-counter capsule (Cochrane IV magnesium).
Can vitamin D prevent asthma attacks?
Not reliably in the general asthma population studied so far. Updated Cochrane evidence did not find support for vitamin D supplementation to reduce asthma exacerbations or improve control, although severe asthma and very low baseline vitamin D were poorly represented (PubMed Cochrane vitamin D review).
Is fish oil good for asthma?
Fish oil and other omega-3 forms have weak/mixed asthma evidence. A systematic review found no strong support for clinical effectiveness and no consistent objective lung-function benefit (omega-3 asthma systematic review).
Does vitamin C help exercise-induced asthma?
Small studies suggested possible exercise-induced breathlessness benefits, but Cochrane judged the evidence inconclusive and not strong enough to guide treatment (Cochrane vitamin C summary).
Are essential oils safe for asthma?
Essential oils are not proven asthma treatments and may trigger respiratory symptoms in sensitive people. AAAAI found no asthma studies of diffused oils and noted that volatile organic compounds can trigger respiratory symptoms (AAAAI essential oils).
Are homeopathic asthma remedies evidence-based?
No reliable evidence supports relying on homeopathy for asthma. Cochrane concluded that evidence is insufficient to assess homeopathy’s role in asthma (Cochrane homeopathy asthma).
Why are lobelia and coltsfoot risky?
Lobelia lacks human asthma evidence and can depress breathing at higher doses, while coltsfoot contains pyrrolizidine alkaloids associated with liver toxicity and carcinogenic concerns (MSK Lobelia, coltsfoot carcinogenicity PubMed).
Can apple cider vinegar help asthma?
No reliable evidence supports apple cider vinegar for asthma, and National Asthma Council Australia explicitly states there is no evidence it is beneficial for asthma (National Asthma Council Australia).
Sources
- GINA 2025 Summary Guide for Asthma Management and Prevention
- Cochrane — Magnesium sulfate for acute asthma
- Cochrane/PubMed — Vitamin D for the management of asthma
- Lancet Respiratory Medicine/PMC — Vitamin D supplementation to prevent asthma exacerbations
- BMC Complementary Medicine/PMC — Treating asthma with omega-3 fatty acids
- Cochrane/PubMed — Vitamin C for asthma and exercise-induced bronchoconstriction
- Cochrane — Vitamin C for asthma and exercise-induced breathlessness
- Cochrane/PubMed — Selenium supplementation for asthma
- PubMed — Vitamin E supplements in asthma RCT
- Cochrane — Homeopathy for chronic asthma
- NCCIH — Butterbur
- LiverTox — Butterbur
- MSK — Lobelia
- PubMed — Carcinogenic activity of coltsfoot
- PMC — Coltsfoot review
- PubMed — Hepatotoxicity of pyrrolizidine alkaloids
- AAAAI — Essential oil diffusers and asthma
- PMC — Essential oils, asthma, thunderstorms, and plant gases
- National Asthma Council Australia — Asthma myths and apple cider vinegar
- NIH ODS — Omega-3 Fatty Acids
- NIH ODS — Vitamin D
- NIH ODS — Magnesium
- NIH ODS — Vitamin C
- Cochrane — Antioxidant supplements and mortality